These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37456582)

  • 21. Enhancement of anti-PD-1/PD-L1 immunotherapy for osteosarcoma using an intelligent autophagy-controlling metal organic framework.
    Ge YX; Zhang TW; Zhou L; Ding W; Liang HF; Hu ZC; Chen Q; Dong J; Xue FF; Yin XF; Jiang LB
    Biomaterials; 2022 Mar; 282():121407. PubMed ID: 35217343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy-induced nanovaccines implement immunogenicity equivalence for improving cancer chemoimmunotherapy.
    Li R; Hao Y; Roche K; Chen G; Pan W; Wang AZ; Min Y
    Biomaterials; 2023 Oct; 301():122290. PubMed ID: 37643488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenic Cell Death: A Step Ahead of Autophagy in Cancer Therapy.
    Gupta G; Borglum K; Chen H
    J Cancer Immunol (Wilmington); 2021; 3(1):47-59. PubMed ID: 34263254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic Reinforcing of Immunogenic Cell Death and Transforming Tumor-Associated Macrophages Via a Multifunctional Cascade Bioreactor for Optimizing Cancer Immunotherapy.
    Huang C; Lin B; Chen C; Wang H; Lin X; Liu J; Ren Q; Tao J; Zhao P; Xu Y
    Adv Mater; 2022 Dec; 34(51):e2207593. PubMed ID: 36245299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanomedicine Enables Drug-Potency Activation with Tumor Sensitivity and Hyperthermia Synergy in the Second Near-Infrared Biowindow.
    Liu W; Xiang H; Tan M; Chen Q; Jiang Q; Yang L; Cao Y; Wang Z; Ran H; Chen Y
    ACS Nano; 2021 Apr; 15(4):6457-6470. PubMed ID: 33750100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (-)-Guaiol triggers immunogenic cell death and inhibits tumor growth in non-small cell lung cancer.
    Yang X; Yang J; Gu X; Tao Y; Ji H; Miao X; Shen S; Zang H
    Mol Cell Biochem; 2023 Jul; 478(7):1611-1620. PubMed ID: 36441354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death.
    Banstola A; Poudel K; Kim JO; Jeong JH; Yook S
    J Control Release; 2021 Sep; 337():505-520. PubMed ID: 34314800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineering nanomedicines for immunogenic eradication of cancer cells: Recent trends and synergistic approaches.
    Elzoghby AO; Samir O; Emam HE; Soliman A; Abdelgalil RM; Elmorshedy YM; Elkhodairy KA; Nasr ML
    Acta Pharm Sin B; 2024 Jun; 14(6):2475-2504. PubMed ID: 38828160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual-responsive nanosystem based on TGF-β blockade and immunogenic chemotherapy for effective chemoimmunotherapy.
    Huang X; Han L; Wang R; Zhu W; Zhang N; Qu W; Liu W; Liu F; Feng F; Xue J
    Drug Deliv; 2022 Dec; 29(1):1358-1369. PubMed ID: 35506467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppressing autophagy enhances disulfiram/copper-induced apoptosis in non-small cell lung cancer.
    Wu X; Xue X; Wang L; Wang W; Han J; Sun X; Zhang H; Liu Y; Che X; Yang J; Wu C
    Eur J Pharmacol; 2018 May; 827():1-12. PubMed ID: 29547841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coordination and Redox Dual-Responsive Mesoporous Organosilica Nanoparticles Amplify Immunogenic Cell Death for Cancer Chemoimmunotherapy.
    Zhang F; Chen F; Yang C; Wang L; Hu H; Li X; Zheng X; Wang Z; Chang Z; Li T; Li L; Ge M; Du J; Sun W; Dong WF; Shao D
    Small; 2021 Jul; 17(26):e2100006. PubMed ID: 34081391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restoring the Immunity in the Tumor Microenvironment: Insights into Immunogenic Cell Death in Onco-Therapies.
    Hernández ÁP; Juanes-Velasco P; Landeira-Viñuela A; Bareke H; Montalvillo E; Góngora R; Fuentes M
    Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34198850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metal-fluorouracil networks with disruption of mitochondrion enhanced ferroptosis for synergistic immune activation.
    Lei L; Dong Z; Xu L; Yang F; Yin B; Wang Y; Yue R; Guan G; Xu J; Song G; Zhang XB
    Theranostics; 2022; 12(14):6207-6222. PubMed ID: 36168615
    [No Abstract]   [Full Text] [Related]  

  • 34. Turning anecdotal irradiation-induced anti-cancer immune responses into reproducible in situ cancer vaccines via disulfiram/copper-mediated enhanced immunogenic cell death of breast cancer cells.
    Wang X; Guo W; Jia L; Xie L; Kiang J; Wang Y; Wang F; Lin Z; Wang E; Zhang Y; Huang P; Sun T; Zhang X; Bian Z; Tang T; Guo J; Ferrone S
    Res Sq; 2023 Aug; ():. PubMed ID: 37645899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymeric indoximod based prodrug nanoparticles with doxorubicin entrapment for inducing immunogenic cell death and improving the immunotherapy of breast cancer.
    Zang X; Song J; Yi X; Piyu J
    J Mater Chem B; 2022 Mar; 10(12):2019-2027. PubMed ID: 35254372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strange attractors: DAMPs and autophagy link tumor cell death and immunity.
    Hou W; Zhang Q; Yan Z; Chen R; Zeh Iii HJ; Kang R; Lotze MT; Tang D
    Cell Death Dis; 2013 Dec; 4(12):e966. PubMed ID: 24336086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utilizing chemotherapy-induced tumor RNA nanoparticles to improve cancer chemoimmunotherapy.
    Su L; Pan W; Li X; Zhou X; Ma X; Min Y
    Acta Biomater; 2023 Mar; 158():698-707. PubMed ID: 36563773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review.
    Zhai J; Gu X; Liu Y; Hu Y; Jiang Y; Zhang Z
    Front Pharmacol; 2023; 14():1152934. PubMed ID: 37153795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Programmable "triple attack" cancer therapy through
    He QL; Jia BX; Luo ZR; Wang YK; Zhang B; Liao T; Guang XY; Feng YF; Zhang Z; Zhou B
    Chem Sci; 2024 Jul; 15(29):11633-11642. PubMed ID: 39055020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detachable Nanoparticle-Enhanced Chemoimmunotherapy Based on Precise Killing of Tumor Seeds and Normalizing the Growing Soil Strategy.
    Wang L; Ding K; Zheng C; Xiao H; Liu X; Sun L; Omer R; Feng Q; Zhang Z
    Nano Lett; 2020 Sep; 20(9):6272-6280. PubMed ID: 32787161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.